2013
DOI: 10.1016/j.ijrobp.2013.02.022
|View full text |Cite
|
Sign up to set email alerts
|

Stereotactic Body Radiation Therapy for Locally Advanced and Borderline Resectable Pancreatic Cancer Is Effective and Well Tolerated

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

9
234
0
1

Year Published

2015
2015
2022
2022

Publication Types

Select...
8
2

Relationship

1
9

Authors

Journals

citations
Cited by 313 publications
(249 citation statements)
references
References 20 publications
9
234
0
1
Order By: Relevance
“…Resected BRPC and LAPC patients comprise the "neoadjuvant therapy" group. Staging methods at our institution have been previously described (19). BRPC and LAPC patients were initially judged medically fit to tolerate resection without probable distant metastases.…”
Section: Initial Staging and Patientsmentioning
confidence: 99%
“…Resected BRPC and LAPC patients comprise the "neoadjuvant therapy" group. Staging methods at our institution have been previously described (19). BRPC and LAPC patients were initially judged medically fit to tolerate resection without probable distant metastases.…”
Section: Initial Staging and Patientsmentioning
confidence: 99%
“…The combination of gemcitabine and nab-paclitaxel showed improved survival over gemcitabine monotherapy in patients with metastatic pancreatic cancer [19,20]. For localised disease, encouraging results from stereotactic body radiation therapy (SBRT), radiofrequency ablation (RFA) and irreversible electroporation (IRE) have been reported, though evidence from randomised trials is still lacking [21][22][23][24]. However, the aforementioned treatments are often taxing to the patient, have high toxicity rates, or are still lacking evidence of efficacy.…”
Section: Introductionmentioning
confidence: 99%
“…28 Numerous other published trials have also looked at the role of SBRT in the treatment of locally advanced pancreatic cancer. [29][30][31][32][33][34][35][36] In Table 1, we present a selected number of studies addressing this topic.…”
Section: Clinical Outcomes In Patients Treated With Sbrtmentioning
confidence: 99%